The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy
Abstract
To determine the role of aldosterone in mediating cardiovascular damage, we performed ablation/replacement experiments with aldosterone in a rat model of cardiac injury. Administration of angiotensin II and Nomega-nitro-L-arginine methyl ester (L-NAME; nitric oxide synthesis inhibitor) to male rats drinking 1% saline caused hypertension, severe biventricular myocardial necrosis, proteinuria, and fibrinoid necrosis of renal and cardiac vessels. Removal of aldosterone by adrenalectomy or through administration of the selective aldosterone antagonist eplerenone markedly reduced the cardiac and renal damage without significantly altering blood pressure. Aldosterone infusion in adrenalectomized, glucocorticoid-replaced L-NAME/angiotensin II-treated animals restored damage. Thus, we identified aldosterone as a critical mediator of L-NAME/angiotensin II induced vascular damage through mechanisms apparently independent of its effects on systolic blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Pitt, B., Segal, R., Martinez, F. A., Meurers, G., Cowley, A. J., Thomas, I., Deedwania, P. C., Ney, D. E., Snavely, D. B., & Chang, P. I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01187-2 · Cited by 1,665
Essential Hypertension: Renin and Aldosterone, Heart Attack and Stroke
Brunner, H. R., Laragh, J. H., Baer, L., Newton, M. A., Goodwin, F. T., Krakoff, L. R., Bard, R. H., & Bühler, F. R. (1972) · New England Journal of Medicine · doi:10.1056/nejm197203022860901 · Cited by 1,093
Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112528 · Cited by 1,072
Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.
Ribeiro, M. O., Antunes, E., de Nucci, G., Lovisolo, S. M., & Zatz, R. (1992) · Hypertension · doi:10.1161/01.hyp.20.3.298 · Cited by 786
Alderman, M. H., Madhavan, S., Ooi, W. L., Cohen, H., Sealey, J. E., & Laragh, J. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241605 · Cited by 730
Brilla, C. G., Zhou, G., Matsubara, L., & Weber, K. T. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1098 · Cited by 694
Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Khanna, K., Zuckerman, A., & Stier, C. T. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.451 · Cited by 496
Self-citationRole of aldosterone in the remnant kidney model in the rat.
Greene, E. L., Kren, S., & Hostetter, T. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118867 · Cited by 479
Changes in Left Ventricular Anatomy and Function in Hypertension and Primary Aldosteronism
Rossi, G. P., Sacchetto, A., Visentin, P., Canali, C., Graniero, G. R., Palatini, P., & Pessina, A. C. (1996) · Hypertension · doi:10.1161/01.hyp.27.5.1039 · Cited by 328
Role of Aldosterone in Renal Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Zuckerman, A., & Stier, C. T. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.232 · Cited by 310
Self-citationLombès, M., Alfaidy, N., Eugene, E., Lessana, A., Farman, N., & Bonvalet, J.-P. (1995) · Circulation · doi:10.1161/01.cir.92.2.175 · Cited by 292
Robert, V., Heymes, C., Silvestre, J.-S., Sabri, A., Swynghedauw, B., & Delcayre, C. (1999) · Hypertension · doi:10.1161/01.hyp.33.4.981 · Cited by 230
Determinants of cardiac fibrosis in experimental hypermineralocorticoid states
Young, M., Head, G., & Funder, J. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.4.e657 · Cited by 228
Thürmann, P. A., Kenedi, P., Schmidt, A., Harder, S., & Rietbrock, N. (1998) · Circulation · doi:10.1161/01.cir.98.19.2037 · Cited by 196
Tomita, H., Egashira, K., Ohara, Y., Takemoto, M., Koyanagi, M., Katoh, M., Yamamoto, H., Tamaki, K., Shimokawa, H., & Takeshita, A. (1998) · Hypertension · doi:10.1161/01.hyp.32.2.273 · Cited by 192
Cardiovascular complications in patients with primary aldosteronism
Nishimura, M., Uzu, T., Fujii, T., Kuroda, S., Nakamura, S., Inenaga, T., & Kimura, G. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70298-2 · Cited by 160
Myocardial fibrosis: role of angiotensin II and aldosterone
Weber, K. T., Brilla, C. G., Campbell, S. E., Eduardo Guarda, S., Zhou, G., & Sriram, K. (1993) · Steinkopff eBooks · doi:10.1007/978-3-642-72497-8_8 · Cited by 137
Takeda, R., Matsubara, T., Miyamori, I., Hatakeyama, H., & Morise, T. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03347840 · Cited by 132
Vascular Aldosterone in Genetically Hypertensive Rats
Takeda, Y., Miyamori, I., Inaba, S., Furukawa, K., Hatakeyama, H., Yoneda, T., Mabuchi, H., & Takeda, R. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.45 · Cited by 132
Aldosterone and cardiac fibrosis: in vitro studies
Fullerton, M., & Funder, J. W. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.12.1863 · Cited by 115
Jalil, J., Janicki, J. S., Pick, R. L., et al. (1991) · American Journal of Hypertension · doi:10.1093/ajh/4.1.51 · Cited by 98
Albuminuria in untreated patients with primary aldosteronism or essential hypertension
Halimi, J., & Mimran, A. (1995) · Journal of Hypertension · doi:10.1097/00004872-199512010-00054 · Cited by 89
Hou, J., Kato, H., Cohen, R. A., Chobanian, A. V., & Brecher, P. I. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118305 · Cited by 88
Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.
Stier, C. T., Adler, L., Levine, S. R., & Chander, P. N. (1993) · PubMed · Cited by 84
Stanton, B. A., Giebisch, G., Klein-Robbenhaar, G., Wade, J. B., & DeFronzo, R. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111832 · Cited by 80
Quan, Z. Y., Walser, M., & Hill, G. S. (1992) · Kidney International · doi:10.1038/ki.1992.45 · Cited by 69
Camargo, M. J. F., von Lutterotti, N., Campbell, W. G., Pecker, M. S., James, G. D., Timmermans, P. B. M. W. M., & Laragh, J. H. (1993) · Journal of Hypertension · doi:10.1097/00004872-199301000-00006 · Cited by 69
MacLeod, A. B., Vasdev, S., & Smeda, J. S. (1997) · Stroke · doi:10.1161/01.str.28.9.1821 · Cited by 61
Potentiation of angiotensin II action by corticosteroids in vascular tissue
Ullian, M. E. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(96)00053-3 · Cited by 58
Cited by
Monticone, S., D'Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaita, F., & Mulatero, P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30319-4 · Cited by 1,072
Aldosterone induces a vascular inflammatory phenotype in the rat heart
Rocha, R., Rudolph, A. E., Frierdich, G. E., Nachowiak, D. A., Kekec, B. K., Blomme, E. A. G., McMahon, E. G., & Delyani, J. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01096.2001 · Cited by 655
Self-citationPitt, B., Reichek, N., Willenbrock, R., Zannad, F., Phillips, R. A., Roniker, B., Kleiman, J., Krause, S., Burns, D., & Williams, G. H. (2003) · Circulation · doi:10.1161/01.cir.0000091405.00772.6e · Cited by 623
Stabilization of atherosclerotic plaques: New mechanisms and clinical targets
Libby, P., & Aikawa, M. (2002) · Nature Medicine · doi:10.1038/nm1102-1257 · Cited by 580
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
Blasi, E. R., Rocha, R., Rudolph, A. E., Blomme, E. A. G., Polly, M. L., & McMahon, E. G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00929.x · Cited by 542
Self-citation
Metadata
- Authors
- Rocha, R.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2000-10-01
- Volume
- 141
- Issue
- 10
- Pages
- 3871-3878
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2096645292
- Cited by
- 475
- References
- 34
- FWCI
- 18.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.